会 议 简 介
第14届肾素-血管紧张素系统论坛将于2011年4月15～17日在意大利的卡普里岛举行，论坛将以“心血管系统异常新机制的基础与临床”为主题，邀请众多在本领域研究卓有成就的意大利、法国、西班牙、比利时、瑞典、加拿大等国家的著名学者就肾素-血管紧张素系统的最新进展进行全方位、多角度的学术交流，意大利著名心脏病学家Massimo Volpe教授将作为本届论坛的主席。肾素-血管紧张素系统在心血管疾病的病理生理学中占有重要位置，是相关疾病治疗的重要靶点，相信本次论坛的成功召开将有助于广大心血管医生深入理解肾素-血管紧张素系统基础研究与临床应用最新成果，以期达到增进共识、推动实践之目的。
会 议 议 程
FRIDAY APRIL 15TH， 2011
14.00 WELCOME AND INTRODUCTION
M. Volpe (Roma)
I SESSION
PATHOPHYSIOLOGY OF HEART AND VESSELS
Chairmen / G. De Simone (Napoli)， M. Volpe (Roma)
14.20 Signaling mechanisms in left ventricular hypertrophy
B. Trimarco (Napoli)
14.40 Fat， renin-angiotensin system and small arteries
E. Agabiti Rosei (Brescia)
15.00 Genetic aspects of cardiomyopathies
S. Rubattu (Roma)
15.20 Discussion
15.40 FEATURED LECTURE
Chairman / A. Salvetti (Pisa)
Aldosterone synthase inhibition in humans
J. Menard (Paris， France)
16.00 BREAK
16.20 PROS AND CONS
Chairman / M. Volpe (Roma)
Fixed-dose combinations versus liberal combinations in hypertension
C. Borghi (Bologna)， S. Taddei (Pisa)
17.00 Discussion
SYMPOSIUM
Chairman / C. Borghi (Bologna)
New clinical perspectives for Aliskiren use
17.20 Recent highlights on RAAS pathophysiology
A. Morganti (Milano)
17.35 From pharmacological to therapeutic innovation: efficacy and safety data of Aliskiren
M. Volpe (Roma)
17.50 The effects on clinical practice of Aliskiren:future perspectives
B. Trimarco (Napoli)
18.05 Discussion
FOCUS SESSION
Chairmen / C. Ferri (L’Aquila)， C. Savoia (Roma)
Cardiovascular prevention
18.20 Peculiar features in cardiovascular risk management in women
M.G. Modena (Modena)
18.40 Lipids and cardiovascular events in the year 2011 – Residual risk
C. Rapezzi (Bologna)
19.00 Discussion
19.15 End of session
SATURDAY APRIL 16 TH， 2011
09.00 FEATURED LECTURE
Mechanisms of plaque instability
F. Crea (Roma)
09.20 MEET THE EXPERT
Chairman / M. Volpe (Roma)
Recent findings for the clinical management of nephropathy patient
R. Pontremoli (Genova)
09.50 MEET THE EXPERT
Chairman / C. Ferri (L’Aquila)
Sartans are not a homogenous drug class: pharmacological differences and clinical outcomes
G. Grassi (Milano)
10.20 SYMPOSIUM
Chairman / M. Volpe (Roma)
Updates in primary and secondary cardiovascular prevention: from theory to clinical practice
A modern approach to the patient at cardiovascular risk
C. Ferri (L’Aquila)
Effects of RAS inhibition on morbidity and mortality of hemodialysis in patients with heart failure
G. Cice (Napoli)
11.20 BREAK
II SESSION
RENIN ANGIOTENSIN SYSTEM AND RECEPTORS
Chairmen / J. Menard (Paris， France)， M. Volpe (Roma)
11.40 The rise in renin during direct renin inhibition: should we be worried?
J. Danser (Rotterdam， Neetherlands)
12.00 Prorenin/renin receptors
G. Nguyen (Paris， France)
12.20 AT2 receptor agonists
T. Unger (Berlin， Germany)
12.40 Novel concepts in aldosterone signaling – clinical implications
R. Touyz (Montreal， Canada)
13.00 Discussion / Discussione
13.20 LUNCH BREAK
14.30 MEET THE EXPERT
Chairman / E. Agabiti Rosei (Brescia)
Atrial fibrillation: from upstream therapy to antiarhythmic therapy
15.00 MEET THE EXPERT
Chairman / M. Volpe (Roma)
Cardiovascular protection in renal patient: therapeutic management at 360°
R. Pontremoli (Genova)
III SESSION
TREATMENT OF HYPERTENSION
Chairmen / G. Deferrari (Genova)， A. Morganti (Milano)
15.30 BP Control in resistant hypertension: old and new approaches
G. Grassi (Milano)
15.50 Chronic RAAS suppression and evolution of albuminuria
L.M. Ruilope (Madrid， Spain)
16.10 New hypertension guidelines
G. Mancia (Milano)
16.30 Discussion / Discussione
17.00 BREAK
IV SESSION
ATRIAL FIBRILLATION AND THROMBOEMBOLISM
Chairmen / L. De Biase (Roma)， G. Germanò (Roma)
17.30 Management of atrial fibrillation
F. Gaita (Asti)
17.50 New advances in the management of thromboembolism
M. Lettino (Brescia)
18.10 Cardiac arrhythmias in ageing: mechanisms and perspectives
e prospettive
P. Francia (Roma)
18.20 Discussion
18.45 End of session
SUNDAY APRIL 17 TH， 2011
V SESSION
NEW ADVANCES IN DIAGNOSIS AND TREATMENT
OF CARDIOVASCULAR DISEASE
Chairmen / F. Crea (Roma)， M. Volpe (Roma)
09.00 Novel mechenisms in diabetic vascular disease implications for treatment
F. Cosentino (Roma)
09.20 Revisiting mechanisms of restenosis: implication for the modern approach
C. Indolfi (Catanzaro)
09.40 Frontiers in myocardial revascularization
E. Barbato (Bruxelles， Belgium)
10.00 Progress in cardiac electrostimulation
R. Cappato (San Donato Milanese)
10.20 BREAK
VI SESSION
THERAPEUTIC BLOCKADE OF THE RAAS
Chairmen / E. Agabiti Rosei (Brescia)， A. Ferrucci (Roma)
10.40 ARBs and atrial fibrillation
A. Morganti (Milano)
11.00 New hypothesis of treatment of patients with acute heart failure
cardiaco acuto
A.P. Maggioni (Milano)
11.20 Antialdosteronic therapy
B. Waeber (Lausanne， Switzerland)
11.40 ARBs and heart failure management
G. Tocci (Roma)
12.00 Discussion
12.30 Consegna questionario ECM
13.15 Closing remarks
[下一页] [1] [2] [3] [4]